These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 23513419)
1. [Chronic kidney disease--mineral and bone disorder: why and how to control phosphate]. Pavlović D; Katicić D; Josipović J Acta Med Croatica; 2012 Oct; 66 Suppl 2():64-7. PubMed ID: 23513419 [TBL] [Abstract][Full Text] [Related]
10. Phosphate binders for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis: a comparison of safety profiles. Locatelli F; Del Vecchio L; Violo L; Pontoriero G Expert Opin Drug Saf; 2014 May; 13(5):551-61. PubMed ID: 24702470 [TBL] [Abstract][Full Text] [Related]
11. [New Developments in CKD-MBD. New aspects in phosphate binders]. Yokoyama K Clin Calcium; 2014 Dec; 24(12):1815-23. PubMed ID: 25423927 [TBL] [Abstract][Full Text] [Related]
12. Mineral metabolism in chronic kidney disease. Kochanek M; Said A; Lerma EV Dis Mon; 2015 Oct; 61(10):425-33. PubMed ID: 26518114 [No Abstract] [Full Text] [Related]
13. [Management of hyperphosphatemia in dialysis patients: the role of phosphate binders]. Malberti F G Ital Nefrol; 2010; 27 Suppl 52():S47-54. PubMed ID: 21132662 [TBL] [Abstract][Full Text] [Related]
14. An introduction to CKD-MBD research: restart for the future. Fukagawa M; Inaba M; Yokoyama K; Shigematsu T; Ando R; Miyamoto KI; Clin Exp Nephrol; 2017 Mar; 21(Suppl 1):1-3. PubMed ID: 28083765 [No Abstract] [Full Text] [Related]
16. [Newly development of phosphate binders in hyperphosphatemic patients with kidney dysfunction]. Negi S; Yamanaka S; Koreeda D; Yashiro M; Shigematsu T Clin Calcium; 2012 Oct; 22(10):1557-66. PubMed ID: 23023637 [TBL] [Abstract][Full Text] [Related]
17. Chronic kidney disease/bone and mineral metabolism: the imperfect storm. Williams ME Semin Nephrol; 2009 Mar; 29(2):97-104. PubMed ID: 19371800 [TBL] [Abstract][Full Text] [Related]
18. The roles of the skeleton and phosphorus in the CKD mineral bone disorder. Hruska KA; Mathew S Adv Chronic Kidney Dis; 2011 Mar; 18(2):98-104. PubMed ID: 21406294 [TBL] [Abstract][Full Text] [Related]
19. Contemporary management of phosphorus retention in chronic kidney disease: a review. Amiri FS Clin Exp Nephrol; 2015 Dec; 19(6):985-99. PubMed ID: 26032778 [TBL] [Abstract][Full Text] [Related]
20. Integral pharmacological management of bone mineral disorders in chronic kidney disease (part I): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification. Bover J; Ureña-Torres P; Lloret MJ; Ruiz-García C; DaSilva I; Diaz-Encarnacion MM; Mercado C; Mateu S; Fernández E; Ballarin J Expert Opin Pharmacother; 2016 Jun; 17(9):1247-58. PubMed ID: 27156993 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]